Computational analysis of the deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in TYR gene impacting human tyrosinase protein and the protein stability.

Fuente: PubMed
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fan, Wei, Ji, Heng Li, Kakar, Mohibullah, Ahmed, Shabbir, Alobaid, Hussah M, Shakir, Yasmeen
Format: Artículo científico
Sprache:en
Veröffentlicht: PloS one 2024
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1868266280142766083
author Fan, Wei
Ji, Heng Li
Kakar, Mohibullah
Ahmed, Shabbir
Alobaid, Hussah M
Shakir, Yasmeen
author_facet Fan, Wei
Ji, Heng Li
Kakar, Mohibullah
Ahmed, Shabbir
Alobaid, Hussah M
Shakir, Yasmeen
Fan, Wei
Ji, Heng Li
Kakar, Mohibullah
Ahmed, Shabbir
Alobaid, Hussah M
Shakir, Yasmeen
collection PubMed - marine biology
contents Computational analysis of the deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in TYR gene impacting human tyrosinase protein and the protein stability. Fan, Wei Ji, Heng Li Kakar, Mohibullah Ahmed, Shabbir Alobaid, Hussah M Shakir, Yasmeen Monophenol Monooxygenase Humans Polymorphism, Single Nucleotide Protein Stability Computational Biology Binding Sites Mutation Tyrosinase, a copper-containing oxidase, plays a vital role in the melanin biosynthesis pathway. Mutations in the tyrosinase gene can disrupt the hydroxylation of tyrosine, leading to decreased production of 3,4-dihydroxyphenylalanine (DOPA). Consequently, this impairs the subsequent formation of dopaquinone, a key precursor in melanin pigment synthesis. This study aimed to identify the deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) within the TYR gene that exert an influence on the human TYR protein. Additionally, we evaluated the impact of 10 FDA-approved drugs on the protein stability of mutated structures, exploring the potential for inhibitory pharmaceutical interventions. Through various bioinformatics tools, we detected 47900 nsSNPs, particularly K142M, I151N, M179R, S184L, L189P, and C321R, which were found to be the most deleterious variants, decreasing the protein stability. These drugs (Sapropterin, Azelaic Acid, Menobenzone, Levodopda, Mequinol, Arbutin, Hexylresorcinol, Artenimol, Alloin and Curcumin) interacted with the binding sites in four mutant models K142M, I151N, M179R, and S184L proving that these ligands directly bind with the active site of mutant tyrosinase protein to inhibit it's working. On the other hand, two mutant models L189P and C321R did not show any binding site residue interaction with any ligands. In conclusion, this in-silico analysis of deleterious nsSNPs in the TYR gene, coupled with the evaluation of ligands/drugs on mutated tyrosinase structures not only advances our understanding of molecular variations but also highlights promising pathways for targeted inhibitory interventions in the intricate network of melanin biosynthesis.
format Artículo científico
id pubmed_39541331
institution PubMed
language en
publishDate 2024
publisher PloS one
record_format pubmed
spellingShingle Computational analysis of the deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in TYR gene impacting human tyrosinase protein and the protein stability.
Fan, Wei
Ji, Heng Li
Kakar, Mohibullah
Ahmed, Shabbir
Alobaid, Hussah M
Shakir, Yasmeen
Monophenol Monooxygenase
Humans
Polymorphism, Single Nucleotide
Protein Stability
Computational Biology
Binding Sites
Mutation
Computational analysis of the deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in TYR gene impacting human tyrosinase protein and the protein stability. Fan, Wei Ji, Heng Li Kakar, Mohibullah Ahmed, Shabbir Alobaid, Hussah M Shakir, Yasmeen Monophenol Monooxygenase Humans Polymorphism, Single Nucleotide Protein Stability Computational Biology Binding Sites Mutation Tyrosinase, a copper-containing oxidase, plays a vital role in the melanin biosynthesis pathway. Mutations in the tyrosinase gene can disrupt the hydroxylation of tyrosine, leading to decreased production of 3,4-dihydroxyphenylalanine (DOPA). Consequently, this impairs the subsequent formation of dopaquinone, a key precursor in melanin pigment synthesis. This study aimed to identify the deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) within the TYR gene that exert an influence on the human TYR protein. Additionally, we evaluated the impact of 10 FDA-approved drugs on the protein stability of mutated structures, exploring the potential for inhibitory pharmaceutical interventions. Through various bioinformatics tools, we detected 47900 nsSNPs, particularly K142M, I151N, M179R, S184L, L189P, and C321R, which were found to be the most deleterious variants, decreasing the protein stability. These drugs (Sapropterin, Azelaic Acid, Menobenzone, Levodopda, Mequinol, Arbutin, Hexylresorcinol, Artenimol, Alloin and Curcumin) interacted with the binding sites in four mutant models K142M, I151N, M179R, and S184L proving that these ligands directly bind with the active site of mutant tyrosinase protein to inhibit it's working. On the other hand, two mutant models L189P and C321R did not show any binding site residue interaction with any ligands. In conclusion, this in-silico analysis of deleterious nsSNPs in the TYR gene, coupled with the evaluation of ligands/drugs on mutated tyrosinase structures not only advances our understanding of molecular variations but also highlights promising pathways for targeted inhibitory interventions in the intricate network of melanin biosynthesis.
title Computational analysis of the deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in TYR gene impacting human tyrosinase protein and the protein stability.
topic Monophenol Monooxygenase
Humans
Polymorphism, Single Nucleotide
Protein Stability
Computational Biology
Binding Sites
Mutation
url https://pubmed.ncbi.nlm.nih.gov/39541331/